CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Top investment pockets
3.3. Market share analysis, 2017
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the number of ESRD patients
3.4.1.2. Rise in incidence of diabetes & hypertension
3.4.1.3. Benefits of peritoneal dialysis over hemodialysis
3.4.1.4. Shortage of kidneys for transplantation

3.4.2. Restraints

3.4.2.1. Complications associated with peritoneal dialysis
3.4.2.2. Poor demand in underdeveloped countries

3.4.3. Opportunities

3.4.3.1. Rise in demand for home peritoneal dialysis treatment
3.4.3.2. Growth opportunities in the emerging markets

3.4.4. Impact analysis

CHAPTER 4: PERITONEAL DIALYSIS MARKET, BY TREATMENT TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Continuous ambulatory peritoneal dialysis (CAPD)

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Automated peritoneal dialysis (APD)

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: PERITONEAL DIALYSIS MARKET, BY PRODUCT

5.1. Overview

5.1.1. Market size and forecast

5.2. Peritoneal dialysis solutions

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Peritoneal dialysis devices

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Peritoneal dialysis sets

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Peritoneal dialysis catheters

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Other peritoneal dialysis products

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

CHAPTER 6: PERITONEAL DIALYSIS MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Home-based dialysis

6.2.1. Market size and forecast
6.2.2. Market analysis, by country

6.3. Dialysis centers & hospital-based dialysis

6.3.1. Market size and forecast
6.3.2. Market analysis, by country

CHAPTER 7: PERITONEAL DIALYSIS MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. peritoneal dialysis market, by treatment type
7.2.2.1.2. U.S. peritoneal dialysis market, by product
7.2.2.1.3. U.S.peritoneal dialysis market, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada peritoneal dialysis market, by treatment type
7.2.2.2.2. Canada peritoneal dialysis market, by product
7.2.2.2.3. Canada peritoneal dialysis market, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico peritoneal dialysis market, by treatment type
7.2.2.3.2. Mexico peritoneal dialysis market, by product
7.2.2.3.3. Mexico peritoneal dialysis market, by end user

7.2.3. North America peritoneal dialysis market, by treatment type
7.2.4. North America peritoneal dialysis market, by product
7.2.5. North America peritoneal dialysis market, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany peritoneal dialysis market, by treatment type
7.3.2.1.2. Germany peritoneal dialysis market, by product
7.3.2.1.3. Germany peritoneal dialysis market, by end user

7.3.2.2. France

7.3.2.2.1. France peritoneal dialysis market, by treatment type
7.3.2.2.2. France peritoneal dialysis market, by product
7.3.2.2.3. France peritoneal dialysis market, by end user

7.3.2.3. UK

7.3.2.3.1. UK peritoneal dialysis market, by treatment type
7.3.2.3.2. UK peritoneal dialysis market, by product
7.3.2.3.3. UK peritoneal dialysis market, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy peritoneal dialysis market, by treatment type
7.3.2.4.2. Italy peritoneal dialysis market, by product
7.3.2.4.3. Italy peritoneal dialysis market, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain peritoneal dialysis market, by treatment type
7.3.2.5.2. Spain peritoneal dialysis market, by product
7.3.2.5.3. Spain peritoneal dialysis market, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe peritoneal dialysis market, by treatment type
7.3.2.6.2. Rest of Europe peritoneal dialysis market, by product
7.3.2.6.3. Rest of Europe peritoneal dialysis market, by end user

7.3.3. Europe peritoneal dialysis market, by treatment type
7.3.4. Europe peritoneal dialysis market, by product
7.3.5. Europe peritoneal dialysis market, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan peritoneal dialysis market, by treatment type
7.4.2.1.2. Japan peritoneal dialysis market, by product
7.4.2.1.3. Japan peritoneal dialysis market, by end user

7.4.2.2. China

7.4.2.2.1. China peritoneal dialysis market, by treatment type
7.4.2.2.2. China peritoneal dialysis market, by product
7.4.2.2.3. China peritoneal dialysis market, by end user

7.4.2.3. Australia

7.4.2.3.1. Australia peritoneal dialysis market, by treatment type
7.4.2.3.2. Australia peritoneal dialysis market, by product
7.4.2.3.3. Australia peritoneal dialysis market, by end user

7.4.2.4. India

7.4.2.4.1. India peritoneal dialysis market, by treatment type
7.4.2.4.2. India peritoneal dialysis market, by product
7.4.2.4.3. India peritoneal dialysis market, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea peritoneal dialysis market, by treatment type
7.4.2.5.2. South Korea peritoneal dialysis market, by product
7.4.2.5.3. South Korea peritoneal dialysis market, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific peritoneal dialysis market, by treatment type
7.4.2.6.2. Rest of Asia-Pacific peritoneal dialysis market, by product
7.4.2.6.3. Rest of Asia-Pacific peritoneal dialysis market, by end user

7.4.3. Asia-Pacific peritoneal dialysis market, by treatment type
7.4.4. Asia-Pacific peritoneal dialysis market, by product
7.4.5. Asia-Pacific peritoneal dialysis market, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil peritoneal dialysis market, by treatment type
7.5.2.1.2. Brazil peritoneal dialysis market, by product
7.5.2.1.3. Brazil peritoneal dialysis market, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia peritoneal dialysis market, by treatment type
7.5.2.2.2. Saudi Arabia peritoneal dialysis market, by product
7.5.2.2.3. Saudi Arabia peritoneal dialysis market, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Africa peritoneal dialysis market, by treatment type
7.5.2.3.2. South Africa peritoneal dialysis market, by product
7.5.2.3.3. South Africa peritoneal dialysis market, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA peritoneal dialysis market, by treatment type
7.5.2.4.2. Rest of LAMEA peritoneal dialysis market, by product
7.5.2.4.3. Rest of LAMEA peritoneal dialysis market, by end user

7.5.3. LAMEA peritoneal dialysis market, by treatment type
7.5.4. LAMEA peritoneal dialysis market, by product
7.5.5. LAMEA peritoneal dialysis market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Baxter International Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. Cook Medical Inc.

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio

8.3. Fresenius Medical Care AG & Co. KGaA

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. Medtronic Plc.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. Medionics International, Inc.

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. Newsol Technologies Inc.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio

8.7. Poly Medicure Ltd.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance

8.8. Renax Biomedical Tech. Co., Ltd.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio

8.9. Terumo Corporation

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance

8.10. Utah Medical Products, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance